AHNS50
IMPACT OF IMMUNOTHERAPY FOR HEAD AND NECK CANCER ON END-OF-LIFE CARE UTILIZATION AND COSTS
Education / Care Delivery
William J Benjamin, MPH1; Pratyusha Yalamanchi, MD, MPH1; Steven B Chinn, MD, MPH1; Michelle M Chen, MD, MHS2
1Department of Otolaryngology - Head and Neck Surgery, University of Michigan; 2Department of Otolaryngology - Head and Neck Surgery, Cedars Sinai Medical Center
AHNS Annual Meeting
Held during the Combined Otolaryngology
Spring Meetings (COSM)
April 27-28, 2022
Hyatt Regency Dallas
Dallas, TX